Poland· PL-100216990
NeisVac-C
A meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert product containing vaccinum meningococcale classis c coniugatum adsorbatum, registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert is registered in 6 of 19 countries.
Countries holding a registration under ATC J07AH07 (meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert · ATC J07AH07
6 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Vaccinum meningococcale classis C coniugatum adsorbatum
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Poland (PL)
- ATC code
- J07AH07
- ATC class
- Meningokokkus C, gereinigtes Polysaccharid-Antigen, konjugiert
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990734344
- gtin05909990734351
- gtin05909990734368
- gtin05909990734375
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH07
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert, as other registers publish it.
- BelgiumMeningitec 10 µgNuron Biotech
- FinlandMenjugateNovartis Vaccines and Diagnostics S.r.l.
- FinlandMenjugateGlaxosmithkline Vaccines S.r.l.
- FinlandMenjugateGlaxosmithkline Vaccines S.r.l.
- BelgiumMenjugate 10 µgGSK Vaccines
- BelgiumMenjugate 10 µgGSK Vaccines
- FinlandMenjugate KitGlaxosmithkline Vaccines S.r.l.
- FinlandNeisvac-CPfizer Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3f4e7da-d183-4d9b-bc64-a2f7e2c887da GET /v1/drugs/d3f4e7da-d183-4d9b-bc64-a2f7e2c887da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina do wstrzykiwań",
"source": "urpl",
"strength": "10 mcg polisacharydu (O-deacetylowanego) Neisseria meningitidis grupy C (szczep C11) skoniugowany z 10-20 mcg toksoidu tężcowego adsorbowany na wodorotlenku glinu 0,5 mg Al+3/0,5 ml",
"packaging": "05909990734344 ¦ Rp ¦ 53555\n1 amp.-strzyk. 0,5 ml ¦ 2 igły \n05909990734351 ¦ Rp ¦ 53564\n1 amp.-strzyk. 0,5 ml\n05909990734368 ¦ Rp ¦ 53565\n10 amp.-strzyk. 0,5 ml\n05909990734375 ¦ Rp ¦ 53566\n20 amp.-strzyk. 0,5 ml",
"substance": "Toksoid tężcowy 10 - 20 mcg + Polisacharyd (O-deacetylowanego) Neisseria meningitidis grupy C (szczep C11) 10 mcg",
"common_name": "Vaccinum meningococcale classis C coniugatum adsorbatum",
"pl_product_id": "100216990",
"pozwolenie_nr": "16000",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.